Inhibrx Biosciences annual operating margin
2022
2023
2024
2025
Inhibrx Biosciences Operating Margin Growth & History (INBX)
Inhibrx Biosciences's operating margin was −10,386.54% for fiscal 2025.
View full Inhibrx Biosciences company overviewInhibrx Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −10,386.54% | +155337.46 pp |
| 2024 | 2024-12-31 | −165,724.00% | −153545.06 pp |
| 2023 | 2023-12-31 | −12,178.94% | −3314.76 pp |
| 2022 | 2022-12-31 | −8,864.18% | — |
Inhibrx Biosciences quarterly operating margin
Q2.23
Q3.23
Q2.24
Q4.24
Q2.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −2,106.85% | +158791.15 pp |
| Q4 2024 | 2024-12-31 | −49,928.00% | — |
| Q2 2024 | 2024-06-30 | −160,898.00% | −23101.33 pp |
| Q3 2023 | 2023-09-30 | −38,510.08% | — |
| Q2 2023 | 2023-06-30 | −137,796.67% | — |
Inhibrx Biosciences operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Inhibrx Biosciences's operating margin decreased from −8,864.18% to −10,386.54%, a change of −1522.36 percentage points. The latest reported quarter, Q2 2025, shows −2,106.85%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inhibrx Biosciences source filings ↗